Giang Lam 38th Lorne Cancer Conference 2026

Giang Lam

Abstracts this author is presenting:

• Targeting the non-canonical NF-kB pathway using the first-in-class IKKα inhibitor SU1644: An innovative approach to combat inflammation and overcome immunosuppression in advanced prostate cancer — Flash Talks - Round 1